Similar articles for PMID: 22520471

Year	Number of Results
1973	1
1988	1
2005	4
2006	8
2007	16
2008	20
2009	11
2010	7
2011	6
2012	3
2013	2
2015	1
2017	3
2018	1
2024	0

1

TRPV1 antagonists: clinical setbacks and prospects for future development.

Kort ME, Kym PR. Kort ME, et al. Prog Med Chem. 2012;51:57-70. doi: 10.1016/B978-0-12-396493-9.00002-9. Prog Med Chem. 2012. PMID: 22520471 Review. No abstract available.

2

Analgesic potential of TRPV1 antagonists.

Kym PR, Kort ME, Hutchins CW. Kym PR, et al. Biochem Pharmacol. 2009 Aug 1;78(3):211-6. doi: 10.1016/j.bcp.2009.02.014. Epub 2009 Mar 5. Biochem Pharmacol. 2009. PMID: 19481638

3

Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.

Gavva NR, Bannon AW, Hovland DN Jr, Lehto SG, Klionsky L, Surapaneni S, Immke DC, Henley C, Arik L, Bak A, Davis J, Ernst N, Hever G, Kuang R, Shi L, Tamir R, Wang J, Wang W, Zajic G, Zhu D, Norman MH, Louis JC, Magal E, Treanor JJ. Gavva NR, et al. J Pharmacol Exp Ther. 2007 Oct;323(1):128-37. doi: 10.1124/jpet.107.125674. Epub 2007 Jul 25. J Pharmacol Exp Ther. 2007. PMID: 17652633

4

On the thermoregulatory perils of TRPV1 antagonism.

Caterina MJ. Caterina MJ. Pain. 2008 May;136(1-2):3-4. doi: 10.1016/j.pain.2008.02.033. Epub 2008 Mar 24. Pain. 2008. PMID: 18359567 No abstract available.

5

TRPing the switch on pain: an introduction to the chemistry and biology of capsaicin and TRPV1.

Conway SJ. Conway SJ. Chem Soc Rev. 2008 Aug;37(8):1530-45. doi: 10.1039/b610226n. Epub 2008 Jun 20. Chem Soc Rev. 2008. PMID: 18648679 Review.

6

Substituted aryl pyrimidines as potent and soluble TRPV1 antagonists.

Stec MM, Bo Y, Chakrabarti PP, Liao L, Ncube M, Tamayo N, Tamir R, Gavva NR, Treanor JJ, Norman MH. Stec MM, et al. Bioorg Med Chem Lett. 2008 Sep 15;18(18):5118-22. doi: 10.1016/j.bmcl.2008.07.112. Epub 2008 Jul 31. Bioorg Med Chem Lett. 2008. PMID: 18722118

7

Transient Receptor Potential Vanilloid 1 Antagonists Prevent Anesthesia-induced Hypothermia and Decrease Postincisional Opioid Dose Requirements in Rodents.

Garami A, Ibrahim M, Gilbraith K, Khanna R, Pakai E, Miko A, Pinter E, Romanovsky AA, Porreca F, Patwardhan AM. Garami A, et al. Anesthesiology. 2017 Nov;127(5):813-823. doi: 10.1097/ALN.0000000000001812. Anesthesiology. 2017. PMID: 28806222 Free article.

8

Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development.

Rami HK, Thompson M, Stemp G, Fell S, Jerman JC, Stevens AJ, Smart D, Sargent B, Sanderson D, Randall AD, Gunthorpe MJ, Davis JB. Rami HK, et al. Bioorg Med Chem Lett. 2006 Jun 15;16(12):3287-91. doi: 10.1016/j.bmcl.2006.03.030. Epub 2006 Mar 31. Bioorg Med Chem Lett. 2006. PMID: 16580202

9

In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 antagonists.

Perner RJ, DiDomenico S, Koenig JR, Gomtsyan A, Bayburt EK, Schmidt RG, Drizin I, Zheng GZ, Turner SC, Jinkerson T, Brown BS, Keddy RG, Lukin K, McDonald HA, Honore P, Mikusa J, Marsh KC, Wetter JM, George KS, Jarvis MF, Faltynek CR, Lee CH. Perner RJ, et al. J Med Chem. 2007 Jul 26;50(15):3651-60. doi: 10.1021/jm070276i. Epub 2007 Jun 21. J Med Chem. 2007. PMID: 17583335

10

Synthesis of a TRPV1 receptor antagonist.

Yu S, Haight A, Kotecki B, Wang L, Lukin K, Hill DR. Yu S, et al. J Org Chem. 2009 Dec 18;74(24):9539-42. doi: 10.1021/jo901943s. J Org Chem. 2009. PMID: 19928811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

73 results

Results by year